Disclosures for "Effect of Lemborexant on Sleep Onset and Maintenance in Patients with Comorbid Insomnia Disorder and Mild Obstructive Sleep Apnea")
-
Margaret Moline has received personal compensation for serving as an employee of EISAI, INC.. Margaret Moline has received intellectual property interests from a discovery or technology relating to health care. Margaret Moline has received personal compensation in the range of $0-$499 for serving as a review, loan repayment program with NIH.
-
Dr. Cheng has received personal compensation for serving as an employee of Eisai Inc.
-
Dinesh Kumar has received personal compensation for serving as an employee of Eisai.
-
Dr. Ramos has received personal compensation for serving as an employee of Eisai.
-
Dr. Lowe has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai . Dr. Lowe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz. Dr. Lowe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Paladin . Dr. Lowe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sunovion . Dr. Lowe has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eisai . Dr. Lowe has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sunovion . The institution of Dr. Lowe has received research support from Axsome Therapeutics . The institution of Dr. Lowe has received research support from Boehringer Ingelheim .